Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-6901
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2 ; day:5 ; month:8 ; year:2021 ; pages:1-4
Drugs in R & D ; (5.8.2021), 1-4
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-021-00358-z
- URN
-
urn:nbn:de:101:1-2021103010510161985969
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sprute, Rosanne
- Schumacher, Sofie
- Pauls, Martina
- Pauls, Wolfgang
- Cornely, Oliver Andreas
- SpringerLink (Online service)
Other Objects (12)
Cutaneous Metal Hypersensitivity Reaction
Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions
Acute and chronic inflammation alter immunometabolism in a cutaneous delayed-type hypersensitivity reaction (DTHR) mouse model
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Cutaneous hypersensitivity reactions to freshwater cyanobacteria – human volunteer studies
Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
An unexpected role of decorin in delayed-type hypersensitivity
Involvement of the activating receptor NKG2D in cutaneous hypersensitivity drug reactions
Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint?
Immunomodulatory role of reactive oxygen species and nitrogen species during T cell-driven neutrophil-enriched acute and chronic cutaneous delayed-type hypersensitivity reactions
Cutaneous Metal Hypersensitivity Reaction
Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions
Acute and chronic inflammation alter immunometabolism in a cutaneous delayed-type hypersensitivity reaction (DTHR) mouse model
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Cutaneous hypersensitivity reactions to freshwater cyanobacteria – human volunteer studies
Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
An unexpected role of decorin in delayed-type hypersensitivity
Involvement of the activating receptor NKG2D in cutaneous hypersensitivity drug reactions
Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint?
Immunomodulatory role of reactive oxygen species and nitrogen species during T cell-driven neutrophil-enriched acute and chronic cutaneous delayed-type hypersensitivity reactions
Cutaneous Metal Hypersensitivity Reaction
Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions
Acute and chronic inflammation alter immunometabolism in a cutaneous delayed-type hypersensitivity reaction (DTHR) mouse model
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Cutaneous hypersensitivity reactions to freshwater cyanobacteria – human volunteer studies
Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
An unexpected role of decorin in delayed-type hypersensitivity
Involvement of the activating receptor NKG2D in cutaneous hypersensitivity drug reactions
Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint?